Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending February 2027 [Japanese GAAP] (Consolidated)

Business Performance Overview

Consolidated net sales for the interim period were 32,058 million yen, representing a substantial year-on-year increase. Operating income was 2,760 million yen, and ordinary income was the same, both showing strong performance. The Group operates businesses in Creative (Japan & Korea), Medical, Accounting & Legal, CRES, and Other segments, led primarily by the Creative business in Japan and the Medical business. The consolidation of Linktech as a subsidiary is expected to accelerate DX support by leveraging its AI development capabilities. Net income decreased slightly year on year but exceeded plan.

Outlook and Key Impacts

The full-year forecast for FY2027 has been revised, and part of the dividend forecast has been adjusted. By integrating Linktech into the Group, the company aims to generate synergies in AI and DX and expand its customer base. External factors such as foreign exchange and geopolitical risks remain uncertain, but core segments are performing solidly, and the company will explore growth opportunities through additional acquisitions and integrations.